MedPath

University Of California, San Francisco

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

High-Dose 131I-MIBG Therapy Combined With Vincristine and Five Days of Irinotecan for Resistant/Relapsed Neuroblastoma

Phase 1
Completed
Conditions
Neuroblastoma
Interventions
First Posted Date
2011-03-14
Last Posted Date
2019-04-29
Lead Sponsor
University of California, San Francisco
Target Recruit Count
32
Registration Number
NCT01313936
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of California, San Francisco, San Francisco, California, United States

Caries Management by Risk Assessment in Children

Not Applicable
Completed
Conditions
Dental Caries
Interventions
Other: xylitol mints and fluoride varnish
First Posted Date
2011-03-08
Last Posted Date
2012-11-14
Lead Sponsor
University of California, San Francisco
Target Recruit Count
120
Registration Number
NCT01310283
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Pediatric Dental Clinic at UCSF, School of Dentistry and UCSF Pediatric Dentistry Clinica at the Tenderloin Community School, San Francisco, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

The Pediatric Dentistry Clinic at UCSF and Tenderloin Community Elementary School, San Francisco, California, United States

The Effects of Omega-3 Fatty Acids Supplementation on Endothelial Function and Inflammation

Not Applicable
Completed
Conditions
Peripheral Arterial Disease
Interventions
Dietary Supplement: Pro-Omega
Dietary Supplement: Omega 3 Fatty Acid
First Posted Date
2011-03-08
Last Posted Date
2021-11-05
Lead Sponsor
University of California, San Francisco
Target Recruit Count
180
Registration Number
NCT01310270
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of California San Francisco, San Francisco, California, United States

The Effects of a Mediterranean Diet in Pediatric Hyperlipidemia

Phase 1
Completed
Conditions
Hyperlipidemia
First Posted Date
2011-03-04
Last Posted Date
2014-01-27
Lead Sponsor
University of California, San Francisco
Target Recruit Count
10
Registration Number
NCT01308710
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of California, San Francisco, San Francisco, California, United States

Comparing (SIS.NET) to Standard Care in Patients Who Have Completed the Acute Phase of Treatment for Early Breast Cancer

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Behavioral: SIS.NET, Routine Follow-up
First Posted Date
2011-03-04
Last Posted Date
2015-03-09
Lead Sponsor
University of California, San Francisco
Target Recruit Count
102
Registration Number
NCT01308775
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

Maternal, Adiposity, Metabolism, and Stress Study

Not Applicable
Completed
Conditions
Obesity
Gestational Weight Gain
Interventions
Behavioral: Mindful Moms
First Posted Date
2011-03-03
Last Posted Date
2021-01-26
Lead Sponsor
University of California, San Francisco
Target Recruit Count
202
Registration Number
NCT01307683
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University California San Francisco, San Francisco, California, United States

The Effect of Problem Solving Therapy and Antidepressant Therapy on Cerebral Perfusion and Brain Derived Neurotropic Factor (BDNF) in Depressed Elders

Not Applicable
Completed
Conditions
Major Depressive Disorder
Interventions
Behavioral: problem solving therapy
Drug: Sertraline
First Posted Date
2011-03-01
Last Posted Date
2022-05-26
Lead Sponsor
University of California, San Francisco
Target Recruit Count
19
Registration Number
NCT01305889
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Langley Porter Psychiatric Institute, San Francisco, California, United States

Post-operative Sore Throat as Determined by Endotracheal Tube Inflation Technique

Not Applicable
Completed
Conditions
Hoarseness
Dysphagia
Post Operative Sore Throat
Interventions
Device: cuff manometer
First Posted Date
2011-02-28
Last Posted Date
2014-02-26
Lead Sponsor
University of California, San Francisco
Target Recruit Count
141
Registration Number
NCT01305265
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of California San Francisco, San Francisco, California, United States

Impact of a Computer-Assisted SBIRT Program in an HIV Care Setting

Completed
Conditions
Substance Use
First Posted Date
2011-02-23
Last Posted Date
2013-05-22
Lead Sponsor
University of California, San Francisco
Target Recruit Count
210
Registration Number
NCT01300806

Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide

Phase 1
Terminated
Conditions
Non-Hodgkin's Lymphoma
B-cell Lymphoma
First Posted Date
2011-02-23
Last Posted Date
2012-09-26
Lead Sponsor
University of California, San Francisco
Target Recruit Count
6
Registration Number
NCT01300793
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Unviersity of California Medical Center, San Francisco, California, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath